• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    First melanoma trial to target KIT aberrations with imatinib

    The incidence of malignant melanoma is increasing by 4% every year ó the highest of any cancer type

    Pathology Specimen Locator Core

    The Pathology Specimen Locator (PSL) Core has developed and implemented a web-based, center-wide solution that enables investigators to identify, locate, and retrieve formalin-fixed, paraffin-embedded pathology specimens for translational research

    Signaling network connects cancer types and collaborators

    What could have prompted the scientific director of the Center for Thoracic Cancers at MGH to cross over into colorectal cancer research? The answer lies in a signaling network that links the two cancer types

    Twenty-one new members join DF/HCC

    Twenty-one individuals have recently joined DF/HCC

    DF/HCC participates in Minority Cancer Awareness Week

    In recognition of Aprilís National Minority Cancer Awareness Week (NMCAW), April 19-25, Dana-Farber/Harvard Cancer Centerís Initiative to Eliminate Cancer Disparities (IECD) collaborated with community organizations to sponsor a variety of cancer awareness and prevention events throughout the Greater Boston community during the month of April

    DF/HCC Profiled in NCI Cancer Bulletin
    NIH Positively Impacted by Stimulus Package
Displaying results 134 to 140 out of 229